(+) -Kavain

(+) -Kavain, a main kavalactone extracted from Piper methysticum, has anticonvulsive properties, attenuating vascular smooth muscle contraction through interactions with voltage-dependent Na+ and Ca2+ channels[1]. (+) -Kavain is shown to bind at the α4β2δ GABAA receptor and potentiate GABA efficacy[2]. (+) -Kavain is used as a treatment for inflammatory diseases, its anti-inflammatory action has been widely studied[4].

Product Specifications

CAS Number

[500-64-1]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Calcium Channel; GABA Receptor; Sodium Channel

Type

Natural Products

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/__addition__-Kavain.html

Purity

99.98

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

O=C1C=C(OC)C[C@H](/C=C/C2=CC=CC=C2)O1

Molecular Formula

C14H14O3

Molecular Weight

230.26

Precautions

H302, H315, H319, H335

References & Citations

[1]Bradić I, et al. [Hirschsprung's disease -- therapy and results]. Acta Chir Iugosl. 1975;22 (2) :183-95.|[2]Chua HC, et al. Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism. PLoS One. 2016 Jun 22;11 (6) :e0157700.|[3]G. Boonen, et al. In vivo Effects of the Kavapyrones (+) -Dihydromethysticin and (±) -Kavain on Dopamine, 3,4-Dihydroxyphenylacetic Acid, Serotonin and 5-Hydroxyindoleacetic Acid Levels in Striatal and Cortical Brain Regions. Planta Medica 64 (1998) 507-510.|[4]Tang X, et al. Kavain Inhibition of LPS-Induced TNF-α via ERK/LITAF. Toxicol Res (Camb) . 2016 Jan 1;5 (1) :188-196.